Combined action of influenza virus and staphylococcus aureus Panton-Valentine leukocidin provokes severe lung epithelium damage

Journal of Infectious Diseases

Volumn 206, Issue 7, 2012, Pages 1138-1148

  Niemann, Silke ^a,b   Ehrhardt, Christina ^a   Medina, Eva ^c   Warnking, Kathrin ^a   Tuchscherr, Lorena ^a,b   Heitmann, Vanessa ^a   Ludwig, Stephan ^a   Peters, Georg ^a,b   Löffler, Bettina ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Interdisciplinary Center of Clinical Research   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; NEUTRALIZING ANTIBODY; PANTON VALENTINE LEUKOCIDIN; PROTEINASE; PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; CONFERENCE PAPER; DISEASE SEVERITY; ENZYME RELEASE; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS; LUNG ALVEOLUS EPITHELIUM; MOUSE; NECROTIZING PNEUMONIA; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; STAPHYLOCOCCUS AUREUS; SUPERINFECTION;

ANIMALS; BACTERIAL TOXINS; CELL EXTRACTS; CELL LINE; CULTURE MEDIA, CONDITIONED; EPITHELIUM; EXOTOXINS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LEUKOCIDINS; LUNG; MICE; MICE, INBRED C57BL; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEPTIDE HYDROLASES; PNEUMONIA, STAPHYLOCOCCAL; PROTEASE INHIBITORS; STAPHYLOCOCCUS AUREUS; VIRAL LOAD;

EID: 84866099053     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis468     Document Type: Conference Paper

References (37)

1. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-70.
2. Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 1958; 2:233-6.
3. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005; 353:2559-67. (Pubitemid 41785893)
4. Randolph AG, Vaughn F, Sullivan R, et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 2011; 128:e1450-8.
5. Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 2007; 87:3-9. (Pubitemid 44973648)
6. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococ-cus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359:753-9. (Pubitemid 34215075)
7. Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in nec-rotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007; 45:315-21. (Pubitemid 47101027)
8. Woodin AM. Purification of the two components of leucocidin from Staphylococcus aureus. Biochem J 1960; 75:158-65.
9. Löffler B, Hussain M, Grundmeier M, et al. Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 2010; 6:e1000715.
10. Szmigielski S, Prevost G, Monteil H, Colin DA, Jeljaszewicz J. Leuko-cidal toxins of staphylococci. Zentralbl Bakteriol 1999; 289:185-201.
11. Lam WY, Yeung AC, Chu IM, Chan PK. Profiles of cytokine and che-mokine gene expression in human pulmonary epithelial cells induced by human and avian influenza viruses. Virol J 2010; 7:344.
12. Wang SZ, Forsyth KD. The interaction of neutrophils with respiratory epithelial cells in viral infection. Respirology 2000; 5:1-10.
13. Craig A, Mai J, Cai S, Jeyaseelan S. Neutrophil recruitment to the lungs during bacterial pneumonia. Infect Immun 2009; 77: 568-75.
14. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010; 10:427-39.
15. Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A 2010; 107:5587-92.
16. Seyer R, Hrincius ER, Ritzel D, et al. Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice. J Infect Dis 2012; 205:262-71.
17. Tuchscherr L, Medina E, Hussain M, et al. Staphylococcus aureus phe-notype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 2011; 3:129-41.
18. Liles WC, Thomsen AR, O'Mahony DS, Klebanoff SJ. Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin. J Leukoc Biol 2001; 70:96-102. (Pubitemid 32613668)
19. Wang R, Braughton KR, Kretschmer D, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007; 13:1510-4. (Pubitemid 350224240)
20. Korkmaz B, Moreau T, Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopath-ological functions. Biochimie 2008; 90:227-42. (Pubitemid 351187763)
21. Iverson AR, Boyd KL, McAuley JL, Plano LR, Hart ME, McCullers JA. Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis 2011; 203:880-8.
22. Lee MH, Arrecubieta C, Martin FJ, Prince A, Borczuk AC, Lowy FD. A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis 2010; 201:508-15.
23. Tashiro M, Ciborowski P, Klenk HD, Pulverer G, Rott R. Role of Staphylococcus protease in the development of influenza pneumonia. Nature 1987; 325:536-7. (Pubitemid 17056736)
24. Lowy FD. How Staphylococcus aureus adapts to its host. N Engl J Med 2011; 364:1987-90.
25. Mahalingam S, Karupiah G. Chemokines and chemokine receptors in infectious diseases. Immunol Cell Biol 1999; 77:469-75.
26. McAuley JL, Hornung F, Boyd KL, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2007; 2:240-9.
27. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008; 4:e1000115.
28. Cassidy LF, Lyles DS, Abramson JS. Synthesis of viral proteins in poly-morphonuclear leukocytes infected with influenza A virus. J Clin Mi-crobiol 1988; 26:1267-70.
29. Loughman JA, Fritz SA, Storch GA, Hunstad DA. Virulence gene expression in human community-acquired Staphylococcus aureus infection. J Infect Dis 2009; 199:294-301.
30. Anwar S, Prince LR, Foster SJ, Whyte MK, Sabroe I. The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin Exp Immunol 2009; 157:216-24.
31. van Wetering S, Mannesse-Lazeroms SP, Dijkman JH, Hiemstra PS. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J Leukoc Biol 1997; 62:217-26. (Pubitemid 27380794)
32. Garcia-Verdugo I, Descamps D, Chignard M, Touqui L, Sallenave JM. Lung protease/anti-protease network and modulation of mucus production and surfactant activity. Biochimie 2010; 92:1608-17.
33. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton- Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128-32. (Pubitemid 30265628)
34. Lipinska U, Hermans K, Meulemans L, et al. Panton-Valentine leuko-cidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS One 2011; 6:e22864.
35. Cribier B, Prevost G, Couppie P, Finck-Barbancon V, Grosshans E, Piemont Y. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 1992; 185:175-80.
36. Kobayashi SD, Malachowa N, Whitney AR, et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 2011; 204:937-41.
37. Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010; 62:726-59.